Close

Analyst Ratings for Ambrx Biopharma (AMAM)

AMAM Rating Summary

AMAM Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AMAM
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $24.67 (-11.9%) * Over Last 12-Mos
Rating Score: 4 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/16/2024 Baird Joel Beatty Downgrade Neutral
(Outperform)
28.00
(22.00)
27.97
(28.00)
0.11% Details
1/10/2024 JMP Securities Reni Benjamin Downgrade Market Perform
(Market Outperform)
N/A
(N/A)
27.47
(28.00)
1.93% Details